![Preetam Shah](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Preetam Shah
Finanzdirektor/CFO bei
ELICIO THERAPEUTICS, INC.
Vermögen: - $ am 31.07.2026
Profil
Preetam Shah is the founder of Saisarva LLC, founded in 2010.
Dr. Shah is currently the Treasurer, Chief Financial & Strategy Officer at Elicio Therapeutics, Inc. since 2025.
Former positions include Director-Healthcare Investment Banking at Barclays Capital, Inc., Director-Healthcare Investment Banking at Lordes Capital Ltd., Chief Financial Officer, Treasurer & Executive VP at Brainstorm Cell Therapeutics, Inc. from 2019 to 2021, Vice President-Healthcare Investment Banking at Canaccord Genuity, Inc. from 2013 to 2016, Vice President-U.S.
Operations & Investments at Reliance Capital Usa Ventures LLC from 2006 to 2009, and Chief Financial & Accounting Officer at Cidara Therapeutics, Inc. from 2024 to 2025.
Education includes a doctorate from the University of Mississippi Medical Center, an MBA from The Wharton School of the University of Pennsylvania, and an undergraduate degree from McDaniel College.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 16.07.2026 | 0 ( -.--% ) | - $ | 31.07.2026 |
Aktive Positionen von Preetam Shah
| Unternehmen | Position | Beginn |
|---|---|---|
| ELICIO THERAPEUTICS, INC. | Finanzdirektor/CFO | 24.03.2025 |
Ehemalige bekannte Positionen von Preetam Shah
| Unternehmen | Position | Ende |
|---|---|---|
| CIDARA THERAPEUTICS | Finanzdirektor/CFO | 24.02.2025 |
| BRAINSTORM CELL THERAPEUTICS INC. | Finanzdirektor/CFO | 31.08.2021 |
Canaccord Genuity, Inc.
 Canaccord Genuity, Inc. Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | 01.01.2016 |
Saisarva LLC | Gründer | 01.01.2013 |
Reliance Capital Usa Ventures LLC | Chief Investment Officer | 01.01.2009 |
Ausbildung von Preetam Shah
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
69
Beziehungen ersten Grades
11
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 11 |
|---|---|
Brainstorm Cell Therapeutics, Inc.
 Brainstorm Cell Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company, which develops innovative adult stem cell therapeutic products | Health Technology |
Barclays Capital, Inc.
 Barclays Capital, Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
McDaniel College
 McDaniel College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lordes Capital Ltd.
 Lordes Capital Ltd. Investment Banks/BrokersFinance Provides investment banking and advisory services | Finance |
University of Mississippi Medical Center
 University of Mississippi Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Canaccord Genuity, Inc.
Canaccord Genuity, Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cidara Therapeutics, Inc.
 Cidara Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Engages in the discovery, development, and commercialization of novel anti-infectives | Health Technology |
Reliance Capital Usa Ventures LLC | |
Saisarva LLC | |
Elicio Therapeutics, Inc.
 Elicio Therapeutics, Inc. BiotechnologyHealth Technology Develops cancer immunotherapies | Health Technology |
